Coronavirus vaccine safe in early trial; hydroxychloroquine may increase death risk
Friday, 22 May 2020 () The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe.
It induced a rapid immune response in its first human trial, Reuters reports.
This vaccine did not cause any serious adverse effects, though side effects such as fever were noted.
Blood samples from the 108 vaccinated...
Risk of COVID-19 Transmission Inside vs. Outside: Explained With stay-at-home orders loosening across the country, it’s important to remember COVID-19 transmission can and will still happen. Here are..